RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Opiant Pharmaceuticals P/S 2024

Opiant Pharmaceuticals P/S

1.56

Opiant Pharmaceuticals Dividend yield

Ticker

OPNT

ISIN

US6837501039

WKN

A2AFQ6

As of May 22, 2024, Opiant Pharmaceuticals's P/S ratio stood at 1.56, a 0% change from the 0 P/S ratio recorded in the previous year.

The Opiant Pharmaceuticals P/S history

Opiant Pharmaceuticals Aktienanalyse

What does Opiant Pharmaceuticals do?

Opiant Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of medications for the treatment of addiction disorders and acute medical needs. The company was founded in 2006 and is headquartered in Santa Monica, California. Since its inception, Opiant Pharmaceuticals Inc. has developed innovative drugs that can help mitigate the effects of addiction disorders and meet the demand for emergency medications. The company follows a clear business model based on the implementation of clinical trials and the commercialization of the resulting medications. One of Opiant Pharmaceuticals Inc.'s core areas is the development of medications that can be used in the context of opioid overdoses. One of the best-known products is Narcan Nasal Spray, an emergency medication that can be used in cases of opioid overdose. The product is fast, easy, and safe to use and has proven to be highly effective in practice. In addition to the development of medications for the treatment of opioid overdoses, Opiant Pharmaceuticals Inc. has also developed medications for the treatment of alcohol dependence. One of the best-known medications is Nalmefene, sold as Selincro in Europe and Canada. The medication is used in combination with behavioral counseling and has proven to be an effective treatment option for patients with alcohol dependence. Another division of Opiant Pharmaceuticals Inc. is the development of medications for acute medical needs. This includes medications such as Fentanyl Nasal Spray, which can be used for the treatment of acute pain. Another medication is the opioid analgesic Oxycodone combined with Naltrexone, which is used for the treatment of moderate to severe pain. In addition, Opiant Pharmaceuticals Inc. also has a wide range of products in the pipeline that are in various stages of development and clinical trials. These include medications for the treatment of methamphetamine and cocaine dependence, as well as for postoperative nausea and vomiting. The company actively invests in research and development and is constantly striving to develop innovative and effective medications that can help minimize the effects of addiction disorders and meet medical needs. Overall, Opiant Pharmaceuticals Inc. has established itself as a leading provider of medications for the treatment of addiction disorders. The company has an impressive track record in drug development and aims to offer effective treatment options to patients around the world. With a strong pipeline of products and a dedicated leadership team, Opiant Pharmaceuticals Inc. is well-positioned to continue growing in the coming years and establish itself as a leading provider of medications for the treatment of addiction disorders. Opiant Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Opiant Pharmaceuticals's P/S Ratio

Opiant Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Opiant Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Opiant Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Opiant Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Opiant Pharmaceuticals Stock

What is the price-to-earnings ratio of Opiant Pharmaceuticals?

The price-earnings ratio of Opiant Pharmaceuticals is currently 1.56.

How has the price-earnings ratio of Opiant Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Opiant Pharmaceuticals has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Opiant Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Opiant Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Opiant Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Opiant Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Opiant Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Opiant Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Opiant Pharmaceuticals?

Some factors that influence the price-earnings ratio of Opiant Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Opiant Pharmaceuticals pay?

Over the past 12 months, Opiant Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Opiant Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Opiant Pharmaceuticals?

The current dividend yield of Opiant Pharmaceuticals is .

When does Opiant Pharmaceuticals pay dividends?

Opiant Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Opiant Pharmaceuticals?

Opiant Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Opiant Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Opiant Pharmaceuticals located?

Opiant Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Opiant Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Opiant Pharmaceuticals from 5/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/22/2024.

When did Opiant Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Opiant Pharmaceuticals in the year 2023?

In the year 2023, Opiant Pharmaceuticals distributed 0 USD as dividends.

In which currency does Opiant Pharmaceuticals pay out the dividend?

The dividends of Opiant Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Opiant Pharmaceuticals

Our stock analysis for Opiant Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opiant Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.